Blase Polite to Medicare
This is a "connection" page, showing publications Blase Polite has written about Medicare.
Connection Strength
1.128
-
Bending Versus Transforming the Drug Cost Curve: A Matter of Political Will. Cancer J. 2020 Jul/Aug; 26(4):304-310.
Score: 0.506
-
Oncology alternative payment models: lessons from commercial insurance. Am J Manag Care. 2022 03; 28(3):98-100.
Score: 0.142
-
Impact on Oncology Practices of Including Drug Costs in Bundled Payments. J Oncol Pract. 2018 05; 14(5):e259-e268.
Score: 0.108
-
Oncology Pathways-Preventing a Good Idea From Going Bad. JAMA Oncol. 2016 Mar; 2(3):297-8.
Score: 0.094
-
Payment for oncolytics in the United States: a history of buy and bill and proposals for reform. J Oncol Pract. 2014 Nov; 10(6):357-62.
Score: 0.085
-
Achieving a deeper understanding of the implemented provisions of the Affordable Care Act. Am Soc Clin Oncol Educ Book. 2014; e472-7.
Score: 0.081
-
Are venous thromboembolic events associated with subsequent breast and colorectal carcinoma diagnoses in the elderly? A case-control study of Medicare beneficiaries. Cancer. 2006 Feb 15; 106(4):923-30.
Score: 0.047
-
Evaluating the Addition of Clinical and Staging Data to Improve the Pricing Methodology of the Oncology Care Model. JCO Oncol Pract. 2022 11; 18(11):e1899-e1907.
Score: 0.037
-
Cost-effectiveness of Maintenance Capecitabine and Bevacizumab for Metastatic Colorectal Cancer. JAMA Oncol. 2019 02 01; 5(2):236-242.
Score: 0.029